The role of MMP activity in T cells during influenza virus pathogenesis

T细胞中MMP活性在流感病毒发病过程中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): The research proposed in this application will investigate the overall hypotheses that matrix metalloprotease (MMP) activity has a critical role in the migration of T cells that leads to immunity to influenza virus, but that aberrant responses after high dose or highly virulent infections could make T cell-derived MMPs a factor in pathology. Influenza viruses cause significant annual illness and death with recurrent seasonal epidemics and sporadic devastating pandemics. The efficiency of highly pathogenic influenza viruses has been attributed to potent and aberrant inflammatory responses, which can result in severe immunopathological damage and death in humans, as found with the H5N1 virus. T cells can contribute to pulmonary damage by direct lysis of infected cells and the production of pro-inflammatory cytokines. Migration of T cells into the site of inflammation and their effector responses in situ are crucial steps towards immunity, but could also contribute to the high morbidity and mortality associated with pathogenic strains. We hypothesize that the ability of T cells to efficiently cross the lung endothelial barrier and move through the basement membrane, which is essential for their function, is regulated by MMPs. MMPs have the proteolytic capability to mediate cleavage of the collagen network that makes up the basement membrane. T cells can express MMPs and dysregulation of these molecules could have far-reaching consequences. Although, MMP activity has been implicated in a variety of pulmonary diseases, nothing is yet known regarding the function of MMPs in regulating the in vivo T cell response to influenza viruses. In this application we will investigate whether MMP activity in T cells accounts for their migration across the basement membrane of the lung in response to influenza virus and as such enables the development of T cell-mediated pathology. We will investigate the relative contribution of MMP expression in different T cell subpopulations to their function using adoptive transfers of T cells that lack MMP activity by genetic deficiency (MMP2 and MMP9 knock-out) or by inhibition (knock-down by retroviral transduction). In addition we will identify the factors that induce MMP expression in vivo. We will focus on the LFA/ICAM interaction, which regulates CD4/CD8 T cell migration in the lung and the effects of extrinsic cytokine production, since it is associated with pathology. Both can elicit MMP activity in T cells ex vivo. The discovery of new insights into the role(s) of MMP in T cell function during influenza virus pathogenesis could elucidate the balance between immunity and pathology and may therefore have considerable therapeutic relevance. PUBLIC HEALTH RELEVANCE Influenza viruses cause significant annual illness and death with recurrent seasonal epidemics and sporadic devastating pandemics. The goal of the proposed research is to investigate the responses that underlie the development of immunopathology during influenza virus infection. These studies will provide new insights into the regulation of immunity to influenza viruses and might offer a strategy to treat clinical symptoms.
描述(由申请人提供):本申请中提出的研究将调查以下总体假设:基质金属蛋白酶(MMP)活性在T细胞迁移中具有关键作用,导致对流感病毒的免疫,但高剂量或高毒力感染后的异常反应可能使T细胞来源的MMP成为病理学因素。流感病毒每年都会引起重大疾病和死亡,并伴有反复出现的季节性流行病和零星的毁灭性流行病。高致病性流感病毒的有效性归因于强效和异常的炎症反应,其可导致人类严重的免疫病理损伤和死亡,如H5 N1病毒所发现的。T细胞可通过直接裂解受感染细胞和产生促炎细胞因子而导致肺损伤。T细胞向炎症部位的迁移及其原位效应反应是免疫的关键步骤,但也可能导致与致病菌株相关的高发病率和死亡率。我们假设T细胞有效地穿过肺内皮屏障并穿过基底膜的能力是由MMPs调节的,这对T细胞的功能至关重要。MMP具有蛋白水解能力,以介导构成基底膜的胶原网络的裂解。T细胞可以表达MMPs,这些分子的失调可能会产生深远的影响。尽管MMP活性与多种肺部疾病有关,但关于MMP在调节体内T细胞对流感病毒应答中的功能还不清楚。在本申请中,我们将研究T细胞中的MMP活性是否解释了它们响应于流感病毒而穿过肺基底膜的迁移,并且因此能够发展T细胞介导的病理学。我们将研究MMP表达在不同的T细胞亚群的相对贡献,他们的功能使用过继转移的T细胞,缺乏MMP活性的遗传缺陷(MMP 2和MMP 9敲除)或抑制(敲低逆转录病毒转导)。此外,我们将确定在体内诱导MMP表达的因素。我们将重点关注LFA/ICAM相互作用,它调节肺中的CD 4/CD 8 T细胞迁移和外源性细胞因子产生的影响,因为它与病理学相关。两者都可以在离体T细胞中引发MMP活性。在流感病毒发病过程中MMP在T细胞功能中的作用的新见解的发现可以阐明免疫和病理之间的平衡,因此可能具有相当大的治疗相关性。公共卫生相关性流感病毒每年都会引起重大疾病和死亡,并伴有反复出现的季节性流行病和零星的毁灭性大流行。这项研究的目的是调查流感病毒感染期间免疫病理学发展的基础反应。这些研究将为流感病毒免疫调节提供新的见解,并可能提供治疗临床症状的策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bas Baaten其他文献

Bas Baaten的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bas Baaten', 18)}}的其他基金

Imprinting of nasal Th2 cell trafficking during allergic sensitization
过敏致敏过程中鼻部 Th2 细胞运输的印记
  • 批准号:
    9334098
  • 财政年份:
    2016
  • 资助金额:
    $ 22.68万
  • 项目类别:
T cell immunity to influenza virus in the aged nasal mucosa
老化鼻粘膜中T细胞对流感病毒的免疫
  • 批准号:
    8160981
  • 财政年份:
    2011
  • 资助金额:
    $ 22.68万
  • 项目类别:
T cell immunity to influenza virus in the aged nasal mucosa
老化鼻粘膜中T细胞对流感病毒的免疫
  • 批准号:
    8324215
  • 财政年份:
    2011
  • 资助金额:
    $ 22.68万
  • 项目类别:
T cell immunity to influenza virus in the aged nasal mucosa
老化鼻粘膜中T细胞对流感病毒的免疫
  • 批准号:
    8520147
  • 财政年份:
    2011
  • 资助金额:
    $ 22.68万
  • 项目类别:
T cell immunity to influenza virus in the aged nasal mucosa
老化鼻粘膜中T细胞对流感病毒的免疫
  • 批准号:
    8723031
  • 财政年份:
    2011
  • 资助金额:
    $ 22.68万
  • 项目类别:
The role of MMP activity in T cells during influenza virus pathogenesis
T细胞中MMP活性在流感病毒发病过程中的作用
  • 批准号:
    7640779
  • 财政年份:
    2008
  • 资助金额:
    $ 22.68万
  • 项目类别:
The role of MMP activity in T cells during influenza virus pathogenesis
T细胞中MMP活性在流感病毒发病过程中的作用
  • 批准号:
    7511774
  • 财政年份:
    2008
  • 资助金额:
    $ 22.68万
  • 项目类别:

相似海外基金

Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
  • 批准号:
    10682121
  • 财政年份:
    2023
  • 资助金额:
    $ 22.68万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10576370
  • 财政年份:
    2022
  • 资助金额:
    $ 22.68万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10387023
  • 财政年份:
    2022
  • 资助金额:
    $ 22.68万
  • 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10248409
  • 财政年份:
    2019
  • 资助金额:
    $ 22.68万
  • 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
  • 批准号:
    nhmrc : GNT1163111
  • 财政年份:
    2019
  • 资助金额:
    $ 22.68万
  • 项目类别:
    Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10462684
  • 财政年份:
    2019
  • 资助金额:
    $ 22.68万
  • 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
  • 批准号:
    398018062
  • 财政年份:
    2018
  • 资助金额:
    $ 22.68万
  • 项目类别:
    Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9308643
  • 财政年份:
    2017
  • 资助金额:
    $ 22.68万
  • 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9447149
  • 财政年份:
    2017
  • 资助金额:
    $ 22.68万
  • 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
  • 批准号:
    8893915
  • 财政年份:
    2014
  • 资助金额:
    $ 22.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了